Harrington, K. J., Champiat, S., Brody, J. D., Cho, B. C., Romano, E., Golan, T., Hyngstrom, J. R., Strauss, J., Oh, D. Y., Popovtzer, A., Gomez-Roca, C., Perets, R., Kim, S.-B., Wong, D. J., Powell, S. F., Khilnani, A., Jemielita, T., Zhao, Q., Zhao, R., & Ingham, M. (2025). Phase 1 and 2 Clinical Studies of the STING Agonist Ulevostinag With and Without Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors or Lymphomas. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-3630